Clinical Trials Browser

Phase 2/3 × methylnaltrexone × Gastrointestinal × Clear all

NCT04083651 2021-05-07

A Study of Methylnaltrexone Bromide (MNTX) in Participants With Advanced Pancreatic Cancer

Phase 2/3 Withdrawn

Gastrointestinal

Pancreatic Neoplasms